You just read:

Health Canada Approves New Indication for STELARA®* (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Jan 27, 2020, 07:31 ET